Ticagrelor Form II Cardiovascular Ticagrelor Intermediates Anticoagulant Ticagrelor CAS 274693-27-5

• Powder: Yes
• Customized: Non-Customized
• Suitable for: Adult
• Purity: >98%
• Color: White
• Grade: Pharmaceutical Grade
• Model NO.: CAS 274693-27-5
• Transport Package: Alumininum Foli Bags
• Specification: 10g, 50g, 200g, 1kg, 5kg
• Trademark: hhdpharm
• Origin: China

Product Description

Wuhan HHD Supply Ticagrelor Form II Cardiovascular Ticagrelor Intermediates Anticoagulant Ticagrelor CAS 274693-27-5

 

Basic information:

Product Name	TICAGRELOR
CAS	274693-27-5
MF	C23H28F2N6O4S
MW	522.574
EINECS	619-540-9
Boiling point	777.6±70.0 °C
Density	1.67

Description:

Ticagrelor, a new platelet aggregation inhibitor successfully developed by AstraZeneca (U.S.), is the world's first reversible combination orally-administered P2Y12 adenosine diphosphate receptor antagonist.

Usage:
Function of Ticagrelor

It is used to reduce cardiovascular death and heart attacks in patients with acute coronary syndrome (ACS.) Rapid onset after oral administration, and can effectively improve symptoms of patients with ACS. Thienopyridines is a reversible P2Y12 inhibitor, so it is particularly applicable towards patients who need to undergo anticoagulant therapy before surgery.

Application of Ticagrelor

It is used to reduce cardiovascular death and heart attacks in patients with acute coronary syndrome (ACS.) Rapid onset after oral administration, and can effectively improve symptoms of patients with ACS. Thienopyridines is a reversible P2Y12 inhibitor, so it is particularly applicable towards patients who need to undergo anticoagulant therapy before surgery.